PORTAL VEIN THROMBOSIS
Clinical trials for PORTAL VEIN THROMBOSIS explained in plain language.
Never miss a new study
Get alerted when new PORTAL VEIN THROMBOSIS trials appear
Sign up with your email to follow new studies for PORTAL VEIN THROMBOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Stent procedure offers hope for cancer patients with dangerous vein blockages
Disease control CompletedThis study tested a procedure to place a small metal tube (stent) in the main vein of the liver to relieve serious symptoms like fluid buildup or bleeding caused by cancer blocking the vein. Researchers looked at 63 patients who had this treatment over 20 years. They checked how …
Matched conditions: PORTAL VEIN THROMBOSIS
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated May 26, 2026 05:50 UTC
-
New combo therapy shows promise for tough liver cancer cases
Disease control CompletedThis study tested a three-drug approach for people with advanced liver cancer that has spread into the main blood vessel of the liver (portal vein). The treatment combines chemotherapy given directly into the liver artery with two oral drugs (lenvatinib and a PD-1 inhibitor). The…
Matched conditions: PORTAL VEIN THROMBOSIS
Phase: PHASE2 • Sponsor: Peking University • Aim: Disease control
Last updated May 26, 2026 05:49 UTC
-
New combo shrinks liver tumors with major vein invasion
Disease control CompletedThis study tested a new treatment for advanced liver cancer that has spread into the main blood vessels of the liver. 63 patients received proton beam radiation to the tumor, followed by a combination of atezolizumab (immunotherapy) and bevacizumab (targeted therapy). The goal wa…
Matched conditions: PORTAL VEIN THROMBOSIS
Phase: PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
Computer model helps cirrhosis patients get right blood thinner dose faster
Knowledge-focused CompletedThis study tested whether a computer program (Simcyp) could help doctors choose the right starting dose of warfarin, a blood thinner, for 21 patients with liver cirrhosis and a blood clot in the portal vein. The goal was to reach a safe and effective level of blood thinning more …
Matched conditions: PORTAL VEIN THROMBOSIS
Phase: PHASE4 • Sponsor: Kafrelsheikh University • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC